[
  {
    "ts": null,
    "headline": "A Look At Charles River Laboratories (CRL) Valuation After Planned CEO Transition And Governance Shift",
    "summary": "Charles River Laboratories International (CRL) has outlined a planned leadership change, with longtime Chair, President, and CEO James C. Foster set to retire in May 2026 and current COO Birgit Girshick appointed as his successor. See our latest analysis for Charles River Laboratories International. The CEO succession news comes as momentum in the shares has been strong, with a 90 day share price return of 29.02% and a 1 year total shareholder return of 14.69%. However, the 5 year total...",
    "url": "https://finnhub.io/api/news?id=c6f567dc6fb8211579a22d22d97cceb63ef3d8bbd73812f262589399756058e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767989684,
      "headline": "A Look At Charles River Laboratories (CRL) Valuation After Planned CEO Transition And Governance Shift",
      "id": 138052973,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River Laboratories International (CRL) has outlined a planned leadership change, with longtime Chair, President, and CEO James C. Foster set to retire in May 2026 and current COO Birgit Girshick appointed as his successor. See our latest analysis for Charles River Laboratories International. The CEO succession news comes as momentum in the shares has been strong, with a 90 day share price return of 29.02% and a 1 year total shareholder return of 14.69%. However, the 5 year total...",
      "url": "https://finnhub.io/api/news?id=c6f567dc6fb8211579a22d22d97cceb63ef3d8bbd73812f262589399756058e5"
    }
  },
  {
    "ts": null,
    "headline": "Tempus AI Stock Surges 82.4% in a Year: What's Driving It?",
    "summary": "TEM shares are up 82.4% in a year as Genomics revenues surge, Data & Services scale, FDA clearances and EBITDA turns positive.",
    "url": "https://finnhub.io/api/news?id=c1858a4e04dea161181c265d1eb029e8c13b304177057c632ab051bd2797f744",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767962700,
      "headline": "Tempus AI Stock Surges 82.4% in a Year: What's Driving It?",
      "id": 138045680,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "TEM shares are up 82.4% in a year as Genomics revenues surge, Data & Services scale, FDA clearances and EBITDA turns positive.",
      "url": "https://finnhub.io/api/news?id=c1858a4e04dea161181c265d1eb029e8c13b304177057c632ab051bd2797f744"
    }
  }
]